Table 3 Effect of clinical subgroups on oligodendrocyted adjacent to microglia and myelin
Oligodendrocytes adjacent to microglia | |||||||
---|---|---|---|---|---|---|---|
Controls (n=20) | SPNS (n=9) | SPPS (n=12) | F(2,36) | p-value | Cohen’s d SPNS/Controls | Cohen’s d SPPS/Controls | |
Area of oligodendrocyte (μm2) | 61.51±2.6 | 62.59±3.6 | 64.3±4.3 | 0.36 | 0.70 | 0.09 | 0.22 |
Area of nucleus (μm2) | 18.16±1.0 | 17.54±1.4 | 19.11±1.3 | 0.57 | 0.57 | 0.14 | 0.21 |
Area of cytoplasm (μm2) | 43.35±2.0 | 45.05±2.6 | 45.19±3.1 | 0.29 | 0.75 | 0.19 | 0.19 |
Nucleus.cytoplasm ratio | 0.43±0.0 | 0.39±0.0 | 0.43±0 | 0.52 | 0.60 | 0.33 | 0.06 |
Area of mitochondria (μm2) | 0.51±0.0 | 0.5±0.0 | 0.5±0.0 | 0.08 | 0.92 | 0.21 | 0.17 |
Vv of mitochondria (%) | 4.53±0.5 | 3.03±1.0 | 2.49±0.3 | 3.91 | 0.03* | 0.63 | 1.04 |
N of mitochondria | 3.7±0.3 | 2.76±0.9 | 2.19±0.2 | 3.39 | 0.04* | 0.52 | 1.10 |
Area of vacuoles (μm2) | 1.38±0.3 | 0.97±0.1 | 1.77±0.5 | 0.66 | 0.52 | 0.33 | 0.27 |
Vv of vacuoles (%) | 0.92±0.2 | 1.18±0.4 | 2.38±0.4 | 6.92 | <0.01** | 0.27 | 1.11 |
N of vacuoles | 0.35±0.1 | 0.72±0.3 | 0.78±0.2 | 3.20 | 0.05 | 0.63 | 0.97 |
Area of lipofuscin granules (μm2) | 1.62±0.3 | 1.67±0.3 | 1.61±0.3 | 0.01 | 0.99 | 0.05 | 0.01 |
Vv of lipofuscin granules (%) | 0.64±0.2 | 2.04±0.6 | 1.81±0.3 | 8.41 | <0.01** | 1.08 | 1.08 |
N of lipofuscin granules | 0.19±0.0 | 0.54±0.1 | 0.58±0.1 | 8.01 | <0.01** | 1.15 | 1.07 |
Cell density (N/mm2) | 69.04±9.9 | 53.33±11.1 | 64.88±7.0 | 0.49 | 0.62 | 0.38 | 0.11 |
Oligodendrocytes adjacent to myelinated fibers | |||||||
Controls (n=20) | SPNS (n=9) | SPPS (n=12) | F(2,36) | p-value | Cohen’s d SPNS/Controls | Cohen’s d SPPS/Controls | |
Area of oligodendrocyte (μm2) | 63.43±2.4 | 64.48±3.0 | 65.48±3.2 | 0.11 | 0.89 | 0.10 | 0.19 |
Area of nucleus (μm2) | 20.08±0.7 | 20.42±1.5 | 21.51±1.0 | 0.56 | 0.58 | 0.09 | 0.43 |
Area of cytoplasm (μm2) | 43.34±1.9 | 44.06±2.2 | 43.97±2.3 | 0.02 | 0.98 | 0.09 | 0.07 |
Nucleus.cytoplasm ratio | 0.47±0.0 | 0.47±0.0 | 0.49±0.0 | 0.35 | 0.71 | 0.01 | 0.36 |
Area of mitochondria (μm2) | 0.53±0.0 | 0.5±0.0 | 0.59±0.1 | 0.57 | 0.57 | 0.36 | 0.27 |
Vv of mitochondria (%) | 4.21±0.3 | 2.73±0.7 | 2.51±0.4 | 4.67 | 0.02* | 0.83 | 1.02 |
N of mitochondria | 3.42±0.3 | 2.29±0.5 | 2.23±0.4 | 3.26 | 0.05 | 0.81 | 0.84 |
Area of vacuoles (μm2) | 1.67±0.3 | 1.55±0.3 | 1.11±0.2 | 0.83 | 0.44 | 0.12 | 0.55 |
Vv of vacuoles (%) | 0.77±0.2 | 0.99±0.2 | 1.53±0.3 | 4.09 | 0.03* | 0.32 | 0.78 |
N of vacuoles | 0.22±0.0 | 0.29±0.1 | 0.69±0.1 | 11.53 | <0.01*** | 0.35 | 1.14 |
Area of lipofuscin granules (μm2) | 1.89±0.4 | 1.9±0.2 | 1.75±0.3 | 0.21 | 0.81 | 0.01 | 0.11 |
Vv of lipofuscin granules (%) | 0.77±0.2 | 2.04±0.4 | 1.61±0.5 | 5.22 | 0.01* | 1.16 | 0.69 |
N of lipofuscin granules | 0.19±0.0 | 0.49±0.1 | 0.49±0.2 | 4.95 | 0.01* | 1.14 | 0.76 |
Cell density (N/mm2) | 144.2±22.0 | 122.5±18.5 | 84.45±18.5 | 1.76 | 0.19 | 0.25 | 0.65 |